UsmanBaberMD
Cardiology • Oklahoma City, OKAdult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Medicine, Icahn School of Medicine at Mount Sinai
Dr. Baber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Stanton L Young Blvd
Oklahoma City, OK 73104Phone+1 405-271-4742
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Interventional Cardiology, 2010 - 2011- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2007 - 2010
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
OK State Medical License 2020 - 2025
NY State Medical License 2007 - 2021- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 592 citationsTicagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, David J. Cohen, Dominick J. Angiolillo
The New England Journal of Medicine. 2019-09-26 - 54 citationsTicagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.Javier Escaned, Davide Cao, Usman Baber, Johny Nicolas, Samantha Sartori
European Heart Journal. 2021-12-01 - 167 citationsDeep learning for cardiovascular medicine: a practical primer.Chayakrit Krittanawong, Kipp W. Johnson, Robert S. Rosenson, Zhen Wang, Mehmet Aydar
European Heart Journal. 2019-07-01
Journal Articles
- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent ImplantationMitchell Krucoff, Usman Baber, JAMA Cardiology
- Temporal Trends, Determinants, and Impact of High-Intensity Statin Prescriptions After Percutaneous Coronary InterventionGeorge Dangas, Serdar Farhan, Samin Sharma, Jason C Kovacic, Nitin Barman, Pedro Moreno, Joseph Sweeny, Birgit Vogel, Usman Baber, Roxana Mehran, ScienceDirect
- Determinants of Significant Out-of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary InterventionJoseph Sweeny, George Dangas, Usman Baber, Serdar Farhan, Birgit Vogel, Samin Sharma, Nitin Barman, Gennaro Giustino, Thrombosis and Haemostasis
- Join now to see all
Lectures
- Duration of Dual Antiplatelet Therapy After PCICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- TWILIGHT: A Deep DiveCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Join now to see all
Press Mentions
High Consumption of Coffee Could Put Your Heart at Risk, Study FindsAugust 17th, 2024- OU Health Milestone with Catheter-Based Mitral Valve RepairMarch 14th, 2023
- ‘Common’ Medication Nonadherence in CV Trials Impacts Outcomes, Regardless of InterventionAugust 15th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
